BevCanna Enterprises

VOYAGEUR PHARMACEUTICALS OTCMKTSVYYRF STOCK QUOTE

https://voyageurpharmaceuticals.ca/

LATEST NEWS FROM VOYAGEUR PHARMACEUTICALS

Voyageur Pharmaceuticals Ltd., Announces The Creation of a New Scientific Advisory Board With World Class Leading Physicians

Voyageur Pharmaceuticals Ltd. Announces Update To PEA and a Related New Opportunity To Market High Purity USP Barium Sulfate

Voyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options and Deferred Share Units

Voyageur Pharmaceuticals Announces Board of Director Changes and 2nd quarter Financial Results

Voyageur Pharmaceuticals Ltd. Announces Completion of Private Placement

Voyageur Pharmaceuticals Ltd. Announces Closing of Second Tranche of Private Placement

Voyageur Pharmaceuticals Ltd. Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast

Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast

Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product Licenses for MultiXThin Radiographic Barium Contrast

Voyageur Pharmaceuticals Ltd. Issued 4th Health Canada License For Radiographic Barium Contrast Product

Voyageur Pharmaceuticals Ltd. Announces Increase to Private Placement

Recent Decision from DC Circuit Court Likely to Result in Less Cost and Faster Approvals for Voyageur Barium Products - Voyageur Hires Team of Experts to Support Product Roll-Out

Voyageur Pharmaceuticals Ltd. Announces up to $1,725,000 Private Placement Financing

Voyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options

Voyageur Pharmaceuticals Ltd. Announces Two Health Canada Approvals and Issuance of Product Licenses for MultiX Ba; Radiographic Barium Contrast

Voyageur Pharmaceuticals Ltd. Signs Manufacturing Agreement With Alberta Veterinarian Laboratories Ltd. for Barium Radiographic Contrast Production

Voyageur Pharmaceuticals Ltd. Receives $209,764.05 from Exercise of Warrants and Options

Voyageur Pharmaceuticals Ltd. Announces Second Health Canada Approval and Issuance of Product License for HDXBa; Radiographic Barium Contrast

Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product License for SmoothX; Radiographic Barium Contrast Suspension